Tyra Biosciences, Inc. - stock earnings
TYRA Quarterly earnings
Date | Earnings | Revenue |
---|---|---|
2023Q4 | -22.8 million USD | ? USD |
2023Q3 | -21.2 million USD | ? USD |
2023Q2 | -13.3 million USD | ? USD |
2023Q1 | -9.4 million USD | ? USD |
2022Q4 | 19.5 million USD | ? USD |
2022Q3 | -11.4 million USD | ? USD |
2022Q2 | -14.8 million USD | ? USD |
2022Q1 | -14.8 million USD | ? USD |
2021Q4 | -9.9 million USD | ? USD |
2021Q3 | -6.6 million USD | ? USD |
2021Q2 | -5.5 million USD | ? USD |
2021Q1 | -4.2 million USD | ? USD |
2020Q4 | -3.7 million USD | ? USD |
2020Q3 | -2.3 million USD | ? USD |
TYRA Yearly earnings
Date | Earnings | Revenue |
---|---|---|
2023 | -69.1 million USD | ? USD |
2022 | -51.7 million USD | ? USD |
2021 | -26.1 million USD | ? USD |
2020 | -9.3 million USD | ? USD |
2019 | -4.1 million USD | ? USD |
TYRA
Price: $15.67
52 week price:
Earnings Per Share: -1.62 USD
P/E Ratio: -13.16
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 1674
Market Capitalization: 945.4 million